54

Cian Healthcare LtdBOM 542678

Последний отчетный период 31 мар., 2024

Обновлено 19 сент., 2024

Последняя цена

Капитализация млрд. $

0.017

Micro

Биржа

XBOM - Bombay Stock Exchange

Анализ акций 542678.BO

54

Нет оценки

Количественный анализ Eyestock не покрывает акции Cian Healthcare Ltd.

Рейтинг

Для оценки качества бизнеса компании мы собрали все финансовые данные из отчетов и представили их в виде одного числа - рейтинга компании. Значение рейтинга 100 является пороговым для определения актуальной инвестиционной идеи.

27/100

Низкий рейтинг

Капитализация млрд. $

0.017

Дивидендная доходность

Оборот

25 млрд

Сайт компании

https://www.cian.co/

Cian Healthcare Ltd. engages in the development and manufacture of pharmaceuticals, cosmeceuticals, and nutraceutical products. The company is headquartered in Pune, Maharashtra. The company went IPO on 2019-05-23. The firm is engaged in the manufacturing and marketing of pharmaceutical products. The company renders services for Third Party Pharmaceutical Manufacturing. The firm is engaged in manufacturing multiple lines- tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets, and cosmetics. Its portfolio comprises of gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, and vitamins and nutrient products. The firm also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, and Sri Lanka. The company is also engaged in the business of manufacturing cosmetic products. The firm caters to approximately eight segments of the pharma industry (branches of medicines), including 500 brands across 11 product lines. The firm's subsidiary includes Dr. Smith Biotech Private Limited.

Смотреть Секцию: Рейтинг